Zobrazeno 1 - 10
of 218
pro vyhledávání: '"Mikihito Nakamori"'
Autor:
Toshiaki Tsuji, Toshiyasu Ojima, Mikihito Nakamori, Masaki Nakamura, Masahiro Katsuda, Keiji Hayata, Junya Kitadani, Shimpei Maruoka, Toshio Shimokawa, Hiroki Yamaue
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-6 (2019)
Abstract Background Several studies have reported that the triangulating stapling method decreases the incidence of anastomotic stricture after esophagectomy. Our previous randomized controlled trial, however, could not confirm the superiority of the
Externí odkaz:
https://doaj.org/article/17b77ceff4be42349de69c77cf9dcda8
Autor:
Toshiyasu Ojima, Masaki Nakamura, Mikihito Nakamori, Keiji Hayata, Masahiro Katsuda, Junya Kitadani, Shimpei Maruoka, Toshio Shimokawa, Hiroki Yamaue
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-6 (2018)
Abstract Background Laparoscopic gastrectomy (LG) has several benefits as a treatment of gastric cancer (GC), including reduced pain, early recovery of intestinal function, and shorter hospital stay. LG still has several drawbacks, however, including
Externí odkaz:
https://doaj.org/article/3f42da833e244b01a0325be48b4f442e
Autor:
Koichi Tamura, Mikihito Nakamori, Kenji Matsuda, Tsukasa Hotta, Masaki Nakamura, Shozo Yokoyama, Makoto Iwahashi, Naohisa Yamade, Hiroki Yamaue
Publikováno v:
Updates in Surgery.
Autor:
Toshiyasu Ojima, Masaki Nakamura, Mikihito Nakamori, Masahiro Katsuda, Keiji Hayata, Toshiaki Tsuji, Shimpei Maruoka, Hiroki Yamaue
Publikováno v:
Endoscopy International Open, Vol 06, Iss 09, Pp E1093-E1099 (2018)
Background and study aims Interventional endoscopic treatments including the application of glue are becoming more frequently used for the treatment of esophageal fistulas. However, there are no prospective studies of endoscopic treatment for esophag
Externí odkaz:
https://doaj.org/article/16191c8b4d7e41bd9ac50ddda210c68d
Autor:
Junya Kitadani, Toshiyasu Ojima, Keiji Hayata, Hiroki Yamaue, Masaki Nakamura, Masahiro Katsuda, Mikihito Nakamori
Publikováno v:
Oncology. 99:57-61
Objectives: A regimen of S-1 combined with oxaliplatin (SOX) has been widely used as the first-line regimen for advanced gastric cancer. To further improve the antitumor efficacy for gastric cancer patients with peritoneal metastasis, we added nab-pa
Autor:
Hiroki Yamaue, Junya Kitadani, Masaki Nakamura, Mikihito Nakamori, Keiji Hayata, Toshiyasu Ojima, Katsunari Takifuji
Publikováno v:
Surgical Endoscopy. 34:5625-5631
Endoscopic submucosal dissection (ESD) is a standard treatment for early gastric cancers (EGCs), but because of the obscured view and difficulty in submucosal lifting it is time consuming and poses high risk of perforation and bleeding in large lesio
Autor:
Shuji Takiguchi, Takaki Yoshikawa, Hiroshi Yabusaki, Ryunosuke Machida, Mikihito Nakamori, Yuya Sato, M. Watanabe, Seiji Ito, Masanori Tokunaga, Masanori Terashima, Yuichiro Doki, Yukinori Kurokawa, Shinji Hato
Publikováno v:
Gastric Cancer. 24:214-223
Recent studies have found a negative impact of postoperative complications on long-term survival outcomes, but it has not been confirmed by data obtained from a prospective study with a large sample size. This study investigated the impact of postope
Autor:
Akihiro Takeuchi, Masaki Nakamura, Hideki Motobayashi, Toshiyasu Ojima, Shimpei Maruoka, Shinta Tominaga, Keiji Hayata, Naoki Fukuda, Junya Kitadani, Mikihito Nakamori, Hiroki Yamaue, Masahiro Katsuda
Publikováno v:
Oncotarget
Background Administration of landiolol hydrochloride was found to be associated with reduced incidence of atrial fibrillation (AF) after esophagectomy for esophageal cancer in our previous randomized controlled trial (RCT). In addition, reduced incid
Autor:
Keiji Hayata, Mikihito Nakamori, Tomokazu Ohta, Yuji Kitahata, Masahiro Katsuda, Hiroki Yamaue, Hiroaki Hemmi, Izumi Sasaki, Masaki Nakamura, Atsushi Miyamoto, Kenji Matsuda, Takashi Orimo, Soichiro Okura, Toshiyasu Ojima, Yuri Fukuda-Ohta, Yuki Mizumoto, Koji Tamada, Masanaka Sugiyama, Motoki Miyazawa, Tsuneyasu Kaisho
Publikováno v:
British Journal of Cancer
BackgroundCancer peptide vaccines show only marginal effects against cancers. Immune checkpoint inhibitors (ICIs) show significant curative effects in certain types of cancers, but the response rate is still limited. In this study, we aim to improve
Autor:
Mikihito Nakamori, Hiroki Yamaue, Yasushi Ino, Toshiyasu Ojima, Masaki Nakamura, Tomoki Todo, Shuichi Matsumura, Tomoya Kato, Hiroshi Fukuhara
Publikováno v:
Oncology Letters. 22
Currently, gastric cancer is the third most common cause of cancer-associated mortality worldwide. Oncolytic virotherapy using herpes simplex virus (HSV) has emerged as a novel therapeutic strategy against cancer. Telomerase is activated in >90of mal